|
|||||
|
|
The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer |
|
| Authors: | Chu Isabel Blackwell Kimberly Chen Susie Slingerland Joyce |
| Institution: | The Braman Breast Cancer Institute, UM Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL 33136, USA. |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |